首页> 外文期刊>Continuing education in anaesthesia, critical care & pain. >Pharmacology of anaesthetic agents II: inhalation anaesthetic agents
【24h】

Pharmacology of anaesthetic agents II: inhalation anaesthetic agents

机译:麻醉药的药理学II:吸入麻醉药

获取原文
获取原文并翻译 | 示例
           

摘要

The first reports of the use of inhalation anaesthetics such as ether (1846), chloroform (1847), and nitrous oxide (1844) began to emerge in the 1840s. Safety issues with early agents, especially chloroform, were quickly recognized and the search for better inhalation agents began with fluorinated ethers and hydrocarbons becoming the main focus of research and development. Since then halothane and enflurane have passed through common usage but have been largely replaced. The inhalation agents used in modern practice include the fluorinated ethers isoflurane, sevoflurane, and desflurane and the gas nitrous oxide (N_2O). The noble gas xenon has impressive anaesthetic properties, but production costs preclude its widespread use. These modern agents have greatly improved the safety, reliability, and applicability of general anaesthesia.
机译:1840年代开始出现有关吸入麻醉剂(如乙醚(1846年),氯仿(1847年)和一氧化二氮(1844年))的第一批报道。早期制剂,特别是氯仿的安全性问题很快被认识到,寻找更好的吸入剂的研究开始于氟化醚和碳氢化合物,成为研究和开发的主要重点。从那时起,氟烷和环戊烷已通过通用使用,但已被大量替代。现代实践中使用的吸入剂包括氟化醚异氟烷,七氟醚和地氟醚以及气体一氧化二氮(N_2O)。稀有气体氙具有令人印象深刻的麻醉特性,但生产成本阻碍了其广泛使用。这些现代药物大大提高了全身麻醉的安全性,可靠性和适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号